killed-whole hiv-1 vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT01546818)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- killed-whole hiv-1 vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01546818 | Phase 1 | Mar 1, 2012 | Anthony Mills, MD, Inc., Living Hope Clinical Foundation, Sumagen |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Anthony Mills, MD, Inc. | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Living Hope Clinical Foundation | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Sumagen | For profit | 1 | 1 | 1 | 2012 |
3 organizations
Page 1 / 1